Quantcast

Latest Histopathology Stories

2014-09-02 08:29:13

SOUTH SAN FRANCISCO, Calif., Sept. 2, 2014 /PRNewswire/ -- Veracyte, Inc. (Nasdaq: VCYT) today announced that Bonnie H. Anderson, president and chief executive officer, will present in a fireside chat format discussion at the Morgan Stanley Global Healthcare Unplugged Conference 2014 on Monday, September 8, 2014 at 3:25 p.m. ET in New York. The live audio webcast and subsequent replay may be accessed by visiting Veracyte's website at http://investor.veracyte.com. Please connect to...

2014-08-27 08:24:05

MarketOptimizer.org adds new clinical trial report "Fatty Liver Disease Global Clinical Trials Review, H2, 2014" to its store. DALLAS, Aug. 27, 2014 /PRNewswire-iReach/ -- "Fatty Liver Disease Global Clinical Trials Review, H2, 2014 provides data on the Fatty Liver Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Fatty Liver Disease. It includes an overview of the trial numbers and their recruitment status as per the site...

2014-08-05 12:31:41

Active Surveillance Provides Low-Risk Patients Less Harmful Treatment Option NORTHFIELD, Ill., Aug. 5, 2014 /PRNewswire-USNewswire/ -- Prostate cancer is the second leading cause of cancer death in men in the United States. Active surveillance offers low-risk prostate cancer patients a means to avoid the potentially harmful side effects from treatment. Pathologists help determine patient eligibility for active surveillance and today a multi-specialty team published their recommendations for...

2014-07-15 23:10:56

The Fatty Liver Bible & Ezra Protocol review that was just updated by Vkool.com reveals Debra Elkin’s home treatment system that promises efficiency in treating fatty liver and obesity. Seattle, Wa (PRWEB) July 15, 2014 According to the Fatty Liver Bible & Ezra Protocol review recently updated by Vkool.com, this is a helpful guide that provides readers with a wide range of tips and advice on how to resolve fatty liver and obesity. This book consists of 8 chapters including:...

2014-07-11 13:26:52

IOS Press Monitoring formation of amylin plaques using 2-D IR spectroscopy, scientists have observed the creation of temporary intermediate structures, which may explain why proteins aggregate into toxic plaques Amyloid diseases, such as Alzheimer's disease, type 2 diabetes, cataracts, and the spongiform encephalopathies, all share the common trait that proteins aggregate into long fibers which then form plaques. Yet in vitro studies have found that neither the amylin monomer...

2014-06-23 09:37:29

Monash University An international team of scientists led by Monash University researchers has shown how free radicals contribute to type 2 diabetes, obesity and fatty liver disease. Type 2 diabetes and non-alcoholic fatty liver disease are key complications of obesity as 80 per cent of patients with type 2 diabetes are obese, and 75 per cent of patients who are obese or have type 2 diabetes also have fatty liver disease. The team, led by Professor Tony Tiganis from the Department...

2014-06-18 08:28:28

SOUTH SAN FRANCISCO, Calif., June 18, 2014 /PRNewswire/ -- Veracyte, Inc. (Nasdaq: VCYT) today announced that Bonnie H. Anderson, president and chief executive officer, will present at the JMP Securities 2014 Healthcare Conference on Wednesday, June 25, 2014 at 11:30 a.m. ET in New York. The live audio webcast and subsequent replay may be accessed by visiting Veracyte's website at http://investor.veracyte.com. Please connect to the website at least 15 minutes prior to the live...

2014-06-02 08:31:14

ProMark(TM) has Potential to Transform Prostate Cancer Care by Aiding Doctors and Patients with Appropriate Treatment Assessment CAMBRIDGE, Mass., June 2, 2014 /PRNewswire/ -- Today, for the first time, Metamark presents results from the clinical validation study that showed ProMark(TM), the first and only proteomic-based imaging biopsy test, achieved its primary endpoint by accurately differentiating between aggressive and non-aggressive forms of prostate cancer at early stages of...

2014-06-01 08:20:47

The study met the primary endpoint with objective response rates of 41.8% and 32.5% respectively in the 200 mg and 800 mg treatment arms(1,2) EAST HANOVER, N.J., June 1, 2014 /PRNewswire/ -- Novartis announced today the results of a pivotal Phase II trial demonstrating that patients with locally advanced (laBCC) or metastatic basal cell carcinoma (mBCC) taking the investigational oral compound LDE225 (sonidegib) had marked and sustained tumor shrinkage after a median follow-up of...

2014-05-28 08:31:02

SOUTH SAN FRANCISCO, Calif., May 28, 2014 /PRNewswire/ -- Veracyte, Inc. (Nasdaq: VCYT) today announced that Bonnie H. Anderson, president and chief executive officer, will present at the Jefferies 2014 Global Healthcare Conference on Wednesday, June 4, 2014 at 9 a.m. ET in New York. The live audio webcast and subsequent replay may be accessed by visiting Veracyte's website at http://investor.veracyte.com. Please connect to the website at least 15 minutes prior to the live webcast to...


Word of the Day
monteith
  • A large punch-bowl of the eighteenth century, usually of silver and with a movable rim, and decorated with flutings and a scalloped edge. It was also used for cooling and carrying wine-glasses.
  • A kind of cotton handkerchief having white spots on a colored ground, the spots being produced by a chemical which discharges the color.
This word is possibly named after Monteith (Monteigh), 'an eccentric 17th-century Scotsman who wore a cloak scalloped at the hem.'
Related